Analysis of the Chinese Veterinary Drug Raw Material Market in the 33rd Week of 2022

At present, the veterinary drug raw material market is stable, and themarket inquiries and negotiations are still mainly concentrated on doxycyclinehydrochloride, florfenicol, penicillin potassium industrial salt, tylosin,tilmicosin and other categories, and the terminal consumption is lower than inprevious years. So share below market trend for your reference:

1. Tetracycline and Chloramphenicol

Doxycycline hydrochloride:The new production of various doxycyclinehydrochloride projects has not caused major disruption to the market.The marketdemand still controls the price, and the market transaction is more rational.

Oxytetracycline and oxytetracycline hydrochloride:The prices fluctuated upward.

Chlortetracycline hydrochloride:the price is stable,and the demand needs to beimproved.

Thiamphenicol:the price is stable.

Florfenicol:the current market price is 450-470RMB, and theprice remains stable. After a round of price increases at the end of April, theprice has been in a stable stage for two consecutive months. After a slightincrease in July, the price gradually stabilized.In August or September,it isexpected to rise again,pay more attention.

2. Cephalosporins and penicillins

Ceftiofur sodium and ceftiofur hydrochloride:cephalosporin products are generally stable, andthe overall demand needs to be improved.

Amoxicillin: the rising heart is still restless. In the pasttwo weeks, it has tentatively supported the price and competed with the marketdemand. However, the market transaction is affected by various factors, and theprice range is large. Whether the price rise can be successful, we willcontinue to pay attention.

Amoxicillin sodium:stable.

Ampicillin and ampicillin sodium:the price has remained stable in the past month.

3. Aminoglycosides

Neomycin sulfate: At present, the price has tended to the lowestlevel, and the manufacturer has stopped reporting. It is expected that theprice will increase in August.

Spectinomycin hydrochloride : The price has fallen and has entered the lowprice range.

Gentamicin sulfate: stable market trend

Apramycin Sulfate: Prices hit record lows, rebound expected

4. Macrolides, peptides and others

Tilmicosin and Tilmicosin Phosphate: Macrolide products ushered in a collectiveincrease again in July.

Tylosin tartrate: price stability

Tiamulin fumarate: market stability is the mainstay

5. Sulfonamides

Sulfammonomethoxine sodium: stable price.

Sulfachloropyrazine Sodium/SulfachlorodazineSodium/Sulfaquinoxaline Sodium: Price Downtrend.

6. Anti-parasitic

Cypromazine:the supply is tight.